UK markets closed

Zynerba Pharmaceuticals, Inc. (0M40.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.2520+0.1300 (+11.59%)
At close: 07:10PM BST
Sign in to post a message.
  • V
    V.
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) announced positive top-line results from the Phase 2 INSPIRE trial of Zygel (Transdermal CBD gel) on pediatric behavioral and emotional symptoms of 22q11.2 deletion syndrome.

    The total score and all five subscales of the Anxiety, Depression, and Mood Scale showed statistically significant improvements at 14 weeks of treatment compared to baseline.

    All five subscales of the Aberrant Behavior Checklist – Community showed statistically significant improvements at 14 weeks.

    The Pediatric Anxiety Rating Scale showed statistically significant improvements at 14 weeks of treatment.

    The investigators rated 12 of 16 patients as "improved," "much improved," or "very much improved" at week 14, with 62.5% being "much improved" or "very much improved."

    Zygel was well tolerated, and the safety profile was consistent with previously released data from other Zygel clinical trials.
  • j
    john
    Canaccord puts BUY on ZYNE with an $11 target!!! It is looking like launch time!!!
  • T
    Trond
    Positive result.
  • C
    CHARANIA
    They just featured ZYNE on this sites morning watchlist. (http://market-engross.club)
  • j
    john
    Looks like the march to $10 is beginning!!!
  • a
    addmorehops
    getting harder to wake this sleeper but i'm adding here anticipating rip when sector cloud moves
  • j
    john
    This one should be streaking to $5 within the next week! Don't see anything that should hold it back. Also, I hear noise about mergers/acquisitions around the net... Anybody got anything solid about these?
  • j
    john
    Interesting that a bunch of Directors acquired over 20000 shares each!? It may be a sign that something is going to be happening soon to drive the stock up!! Anybody have any other news?
  • R
    R
    Market inefficiencies tend to be temporary. Have to shake my head on this one for sure. Continue to acquire shares, at basically time adjusted cash values.
    All jmho...invest wisely and for the long term, as in 3-5 years, and, do your own due diligence, for starters listen to the most recent webcast.
    GLTA.
  • p
    perno
    I am so tired of ZYNE doing nothing all day. Can you move??? I have been reading (http://Achieverspot.tech) for a month now and the stocks there actually go!
  • S
    Schimanski
    $2 coming..
  • S
    Steve
    Two great shots at orphan drug approval 👏 👌 I'm all in
  • n
    nkov
    Hmmmm, files international patent application. "Cannabidiol for the treatment of refractory seizures"
  • V
    V.
    ZYNE is way oversold. I suppose we will recapture the $1 today.
  • j
    john
    Wow! 7% uptick! What is happening? I like it and hopeit keeps going up!
  • S
    STUTTLE
    Guys, check out (http://Achieverspot.tech). They have been crushing it lately while ZYNE barley does anything at all.
  • S
    Steve
    volume
  • M
    Moneyman
    Nice cannabis gem with blockbuster pipeline ,,, ZYNE is similar company like GW Pharma which getting acquired for $7+ BILLION by Jazz Pharma in last year .
    https://assets.wallstreet-online.de/_media/8763/board/20220328161124-screenshot-2022-03-28-at-16-10-45-powerpoint-pres.png
  • T
    Trond
    Zynerba Pharmaceuticals Files International Patent Application Titled 'CANNABIDIOL FOR THE TREATMENT OF REFRACTORY SEIZURES'
  • D
    Dom
    Next stop $2.21 opened at $0.95 on Thursday. The company has a 50-day simple moving average of $1.33 and a 200 day simple moving average of $2.21. Zynerba Pharmaceuticals has a fifty-two week low of $0.84 and a fifty-two week high of $6.07.